| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Articles |
John D. Dingell Veterans Affairs Medical Center, Department of Internal Medicine and Karmanos Cancer Institute, Wayne State University, Detroit, Michigan 48201
Abstract
Signal transduction via modulation of phosphorylation after
selective inhibition of protein phosphatase (PP) 1 and/or PP2A appears
to play a role in okadaic acid (OA)-mediated effects. Treatment of
several estrogen receptor-negative human breast carcinoma (HBC) cells
with 100 nM OA resulted in induction of
c-fos, c-myc, and cyclin-dependent kinase
inhibitor p21WAF1/CIP1 genes. Transfections
of various luciferase reporter constructs in HBC cells revealed
involvement of activator protein-1-dependent as well as -independent
pathways in induction of the c-fos gene by OA.
MDA-MB-468 HBC cells were stably transfected with plasmids expressing
luciferase, chimeric luciferase- c-fos 3'
untranslated region (3'UTR), or chimeric
luciferase-p21WAF1/CIP1 3'UTR mRNAs.
Expression of chimeric luciferase-c-fos and
luciferase-p21WAF1/CIP1 mRNAs was elevated
by OA in several independent sublines. Actinomycin D chase experiments
revealed an enhanced rate of decay of luciferase-c-fos
mRNA, whereas treatment with OA caused
3.5-fold enhanced stability
of the chimeric luciferase-c-fos mRNA only. By
transfecting different plasmids containing deletions of
c-fos 3'UTR, OA-responsive sequences were mapped to an
86-nucleotide, AU-rich region. UV cross-linking experiments using HBC
cell cytosolic proteins showed multiple complexes with the AU-rich
region subfragments of c-fos, as well as
c-myc and p21WAF1/CIP1
mRNAs. OA enhanced binding of a novel Mr
75,000 protein present in the cytosolic extracts of HBC cells
to the AU-rich RNA probes of all of the above three genes. Taken
together, OA regulation of HBC cell gene expression involves the
activator protein-1 pathway, as well as enhanced binding of a novel
Mr
75,000 protein to an AU-rich region of
the 3'UTRs of the target genes.
This article has been cited by other articles:
![]() |
N. H. Ing, D. A. Massuto, and L. A. Jaeger Estradiol Up-regulates AUF1p45 Binding to Stabilizing Regions within the 3'-Untranslated Region of Estrogen Receptor {alpha} mRNA J. Biol. Chem., January 18, 2008; 283(3): 1764 - 1772. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, A. Wali, C. V. Ramana, and A. K. Rishi Cell Growth Inhibition by Okadaic Acid Involves Gut-Enriched Kruppel-like Factor Mediated Enhanced Expression of c-Myc Cancer Res., November 1, 2007; 67(21): 10198 - 10206. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Keen, Q. Zhou, B. H. Park, C. Pettit, K. M. Mack, B. Blair, K. Brenner, and N. E. Davidson Protein Phosphatase 2A Regulates Estrogen Receptor {alpha} (ER) Expression through Modulation of ER mRNA Stability J. Biol. Chem., August 19, 2005; 280(33): 29519 - 29524. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. K. Nagothu, A. K. Rishi, R. Jaszewski, O. Kucuk, and A. P. N. Majumdar Folic acid-mediated inhibition of serum-induced activation of EGFR promoter in colon cancer cells Am J Physiol Gastrointest Liver Physiol, September 1, 2004; 287(3): G541 - G546. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Rishi, L. Zhang, M. Boyanapalli, A. Wali, R. M. Mohammad, Y. Yu, J. A. Fontana, J. S. Hatfield, M. I. Dawson, A. P. N. Majumdar, et al. Identification and Characterization of a Cell Cycle and Apoptosis Regulatory Protein-1 as a Novel Mediator of Apoptosis Signaling by Retinoid CD437 J. Biol. Chem., August 29, 2003; 278(35): 33422 - 33435. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Seth, M. S. R. Haque, and P. S. Zelenka Regulation of c-fos Induction in Lens Epithelial Cells by 12(S)HETE-Dependent Activation of PKC Invest. Ophthalmol. Vis. Sci., December 1, 2001; 42(13): 3239 - 3246. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |